You, Mei
Liu, Yushuang
Wang, Bowen
Li, Li
Zhang, Hexuan
He, Hongbo
Zhou, Qing
Cao, Tingbing
Wang, Lijuan
Zhao, Zhigang
Zhu, Zhiming
Gao, Peng
Yan, Zhencheng
Clinical trials referenced in this document:
Documents that mention this clinical trial
Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease
https://doi.org/10.1186/s12933-022-01457-0
Funding for this research was provided by:
Key Technologies Research and Development Program (2018YFA0800601)
National Natural Science Foundation of China (82022006)
Natural Science Foundation of Chongqing (cstc2021jcyj-jqX0002, cstc2019jcyj-msxmX0152)
Project of Army Medical Center of PLA (2019CXLCB008)
Article History
Received: 30 November 2021
Accepted: 25 January 2022
First Online: 15 February 2022
Declarations
:
: The study was approved by the Ethics Committee of Army Medical Center of PLA (Number 93/2021) and adhered to the principles of the Declaration of Helsinki. All participants agreed to participate in the study and gave informed consent.
: The consent to publish was obtained from all participants in this study.
: The authors declare that they have no competing interests.